Director, Clinical Science – Oncology Clinical Development GYN

GSK•Upper Providence, PA
•$189,750 - $316,250•Hybrid

About The Position

The Director, Clinical Science – Oncology Clinical Development GYN provides scientific leadership across defined components of study design, conduct, data review, and interpretation within an assigned clinical programme. Reporting to the Clinical Development Lead (CDL), the role operates within the asset-level clinical strategy and contributes scientific depth and rigour to execution of the Clinical Development Plan (CDP). It partners closely with the Senior Scientist and cross-functional teams to support clinical studies, ensuring scientific quality, data integrity, and robust interpretation of clinical data. This scientific individual-contributor role contributes to study-level activities and broader programme insights but is not accountable for asset-level strategy or overall study delivery. The role provides scientific input to protocol development, study design, conduct, and study-level decisions; analyses clinical data; contributes to clinical and regulatory documents and submissions; and works with internal and external stakeholders. It is a core member of the Clinical Matrix Team (CMT), partnering across functions and supporting scientific exchange, programme understanding, and continuous improvement. The position is hybrid, with on-site work at a posted location at least two days per week and remote work available on other days. For candidates located at the Stevenage site, the role will temporarily be based there before a proposed office relocation to Cambridge, UK by early 2029. For specified US locations, the annual base salary range is $189,750–$316,250, with an annual bonus and eligibility for a share-based long-term incentive program dependent on role level. Available benefits include health care and other insurance benefits, retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave.

Requirements

  • Bachelor’s degree in life sciences or a related scientific discipline.
  • Experience in the pharmaceutical or biotechnology industry, or related clinical development experience, focused on oncology.
  • Clinical development experience from early stage through regulatory submission, including study design, protocol authoring, and data review and interpretation.
  • Experience working within GCP, ICH, and global regulatory guidelines.
  • Experience authoring or contributing to clinical study proposals, protocols, Investigator’s Brochures, informed consent forms, Clinical Study Reports, and regulatory submissions.
  • Experience working within cross-functional matrix teams and contributing to clinical decision-making.
  • Proven track record of working with investigators, site staff, external experts, CROs, and vendors.

Nice To Haves

  • Advanced degree (e.g., MS, PhD, or PharmD) in life sciences or a related discipline.
  • Clinical development experience across multiple phases of development (Phase I–IV).
  • GYN Oncology clinical development experience.
  • Experience presenting or preparing materials for Protocol Review Boards, governance meetings, or scientific forums.
  • Knowledge of regulatory requirements to support registration, including experience contributing to IND, EoP2, scientific advice, pre-NDA/BLA, NDA/MAA, or AdCom submissions.

Responsibilities

  • Provide scientific leadership across defined study-level activities, including protocol development, study design, data review, and interpretation, within the strategic direction set by the CDL.
  • Serve as a core member of the Clinical Matrix Team and ensure scientific alignment across study objectives, timelines, and deliverables.
  • Provide scientific insight to the CDL and Senior Scientist to inform asset-level strategy, benefit–risk assessment, and programme-level decisions.
  • Provide scientific input into protocol development and study design, ensuring robustness, feasibility, and alignment with CDP objectives and regulatory requirements.
  • Author or co-author study documents, including Clinical Study Proposals, and contribute to preparation and presentation at governance forums such as Protocol Review Boards.
  • Support study conduct by addressing scientific questions, ensuring data integrity, and maintaining alignment with protocols and regulatory standards.
  • Provide scientific input into study-level decisions concerning protocol implementation and study conduct within the CDL-defined strategic framework.
  • Present the scientific rationale and study design at Investigator Meetings and respond to scientific inquiries from study sites.
  • Support implementation of study-level Go/No-Go criteria aligned with the asset-level decision framework defined by the CDL.
  • Analyse and interpret clinical data to generate insights on safety, efficacy, and patient populations.
  • Integrate internal and external information, including literature, competitor data, and emerging science, to inform study and programme understanding.
  • Contribute to data review and interpretation with Medical Directors and pharmacovigilance.
  • Translate study findings into scientific insights to inform programme progression and CDL-led decisions.
  • Contribute to clinical and regulatory documents, including protocols, Investigator’s Brochures, Clinical Study Reports, and submission materials, ensuring scientific accuracy, consistency, and quality.
  • Support regulatory submissions and responses to Health Authority queries; contribute to reporting requirements such as DSURs and INDSRs.
  • Partner with Clinical Operations, Statistics, Safety, Regulatory, and Medical Affairs to support integrated study delivery.
  • Provide scientific expertise to cross-functional discussions, including integrated evidence planning and disease-area forums, as appropriate.
  • Participate in scientific interactions with investigators, Key External Experts, advisory boards, and collaborators.
  • Contribute to scientific communications, including publications, congress presentations, and study-related materials.
  • Identify study-level scientific and operational risks and provide input into mitigation strategies.
  • Support and drive consistent ways of working and process improvements across the programme.
  • Participate in Oncology Clinical Development initiatives and workstreams to strengthen standards, processes, and capabilities.
  • Continue developing scientific expertise, disease-area knowledge, and broader clinical development capabilities.

Benefits

  • Annual bonus.
  • Eligibility to participate in a share-based long-term incentive program, dependent on role level.
  • Health care and other insurance benefits for employees and family.
  • Retirement benefits.
  • Paid holidays.
  • Vacation.
  • Paid caregiver, parental, and medical leave.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service